OBJECTIVE: 1) Define the role of preoperative investigations for an accurate diagnosis of site/extension of the skull base defect (SBD). 2) Identify different solutions in performing duraplasty, choosing among available techniques/materials. 3) Evaluate the efficacy and safety of the endoscopic endonasal approach in pediatric age. METHOD: From 2000 to 2010, 26 patients (14 males, 12 females, mean age 8.9 years) affected by SBD referred to our Institute. The diagnostic work-up provided endoscopic examination and neuroimaging with CT and MR. Intraoperative intrathecal fluorescein test was performed during surgery to display the defects site/s and ensure a watertight duraplasty. Follow-up was carried out with periodic endoscopic and MR evaluation. RESULTS: Pediatric SBDs represent 9.6% of our experience in cerebrospinal fluid leaks treatment. 14 patients were affected by spontaneous defects, 12 by traumatic defects (2 iatrogenic, 10 accidental). 21 patients were treated with a pure endoscopic technique, 5 patients underwent a combined, endoscopic endonasal and craniotomic surgical approach. Duraplasty was performed with single/double layer (11) or multilayer (15) technique, depending on the site. The most employed materials were autologous. No intra-and postoperative complications were observed. Mean follow up was 5.5 years. CONCLUSION: SBDs are rare conditions, which require surgical treatment in order to avoid serious complications. Our experience highlights that an accurate preoperative assessment of the defect is mandatory to guarantee the proper selection of the surgical technique. The use of dedicated instruments grants a minimally invasive surgical approach, which decreases the risk of functional/aesthetic strings. Larger and longer studies are needed.
The Effectiveness of Childhood Tonsillectomy Janet Wilson, MD, FRCSEd, FRCSEng (presenter) ; Sean Carrie, FRCS; Catherine Lock, MA, PhD; Martin Eccles, MD, FMedSci, FRCP; Nick Steen, PhD OBJECTIVE: To assess the clinical and cost effectiveness of tonsillectomy/adeno-tonsillectomy in children aged 4-15 years with recurrent sore throats. METHOD: Design: A pragmatic randomized controlled Trial (Trial) and a parallel, non-randomized, patient preference arm (Cohort). Participants: 1546 children aged 4 to 15 years referred to secondary care with recurrent sore throats assessed; 1015 eligible; 268 enrolled to the Trial; 461 to the Cohort. Setting: 5 secondary care UK otolaryngology departments. The Trial surgical treatment arm -(adeno) tonsillectomy within 12 weeks of randomization. Control ϭ conventional medical therapy. The primary outcome was the reported number of episodes of sore throat in the two years after study enrollment.
An intention to treat analysis was performed according to the original protocol, followed by an as-treated analysis, incorporating Trial plus Cohort patients. RESULTS: Children randomized to surgery had fewer sore throats [incidence rate ratios year 1: 0.70 (95% CI: 0.61, 0.80), year 2: 0.54 (95% CI: 0.42, 0.70)]. Estimated effect of tonsillectomy by intention to treat ϭ 3.5 fewer sore throats in 2 y. There was a 26% cross over from the medical to the surgical arm. The as treated analysis showed surgery prevented an average of over 8 sore throats in 2 y if performed within 10 weeks of consultation. CONCLUSION: Tonsillectomy is effective at reducing the rates of reported sore throats. The maximum benefit of intervention is achievable by operating as soon as possible after consultation. If there is a high social or educational impact of tonsillitis, this is an important consideration.
The Incidence of Hearing Loss in Trisomy 21
Albert Park, MD (presenter); Paul Stevens, BS; Nancy Hohler, MA; Richard Harward, AuD; Nanette Sturgill, MS OBJECTIVE: 1) Determine the incidence and type of hearing loss in trisomy 21 patients. 2) Ascertain the time for diagnosis of hearing loss in trisomy 21 patients who fail their newborn hearing screening tests. METHOD: Three hundred fourteen Down syndrome patients born in Utah between January 2002 to December 2006 were identified using the Utah Department of Health newborn hearing screening and Down syndrome registry. Newborn hearing tests, follow up studies and exams leading to a diagnosis of normal or impaired hearing were reviewed retrospectively. RESULTS: Seventy-two of trisomy 21 children (22.9%) had hearing loss. Thirteen (4.1%) were diagnosed with sensorineural hearing loss (SNHL); fifty-nine (18.8%) were diagnosed with conductive hearing loss (CHL). Eleven of thirteen patients with SNHL failed their newborn hearing (NBH) screen (2 unavailable). One had a unilateral profound SNHL. Twelve children had bilateral SNHL (mild to profound). Seven were diagnosed within the first 3 months of life and five had hearing aids within a month. The average time to diagnosis was 263 days (SD 388 days).Thirty-eight patients with CHL passed their NBH screen and eighteen failed (3 not available). Twenty-four patients improved their hearing with tubes. The average time to diagnosis for those who failed their initial NBH screen was 330 days (SD 355). CONCLUSION: Trisomy 21 children have a relatively high incidence of both SNHL and CHL. Time to diagnosis for both SNHL and CHL took longer than the recommended guidelines recommended in 2007 from the Joint Committee on Infant Hearing.
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